Long-term Outcome in 7 Patients With Idiopathic Orbital Myositis

Area of Science:

• Ophthalmology
• Neurology
• Rheumatology

Background:

• Idiopathic orbital myositis (IOM) is a rare condition of unknown etiology.
• Diagnosis is challenging, often relying on excluding other orbital diseases.
• Understanding its long-term prognosis is crucial for clinical management.

Purpose of the Study:

• To determine the long-term outcome of idiopathic orbital myositis.
• To ascertain if IOM represents a distinct clinical entity.
• To evaluate the efficacy of corticosteroid treatment in IOM.

Main Methods:

• Retrospective review of 7 consecutive patients diagnosed with IOM.
• Patients were followed for a mean of 9.2 years (minimum 5 years).
• Data included presenting symptoms, MRI findings, and treatment response.

Main Results:

• Presenting symptoms included diplopia, blurred vision, and proptosis.
• MRI revealed extraocular muscle enlargement in all patients.
• No patients developed systemic diseases or other orbital lesions during follow-up.
• All patients achieved symptom resolution with prednisolone treatment.

Conclusions:

• Idiopathic orbital myositis demonstrates a favorable long-term prognosis with corticosteroid therapy.
• The condition appears to be a distinct clinical entity.
• IOM does not typically involve systemic disease or other orbital pathologies.